The 2026 ACC/AHA Dyslipidemia Guideline: A Critical and Transatlantic Perspective on Personalized Lipid Management. (PubMed, Life (Basel)) - Sep 27, 2026 - "Finally, we discuss unresolved issues involving implementation, adherence, access, cost, health equity, inclisiran outcomes, and emerging lipoprotein(a)-lowering therapies. The guideline's impact will depend on translating greater precision into timely, feasible, and equitable care."
Journal • Review • Cardiovascular • Dyslipidemia • Hypertriglyceridemia • Metabolic Disorders • Severe Hypertriglyceridemia • APOB
|
|
Dan Atar; Dario Mafrica; Domenico Mario Giamundo; Elad Asher; Giuseppe Andò; Joanna Popiolek Kalisz; Pierre Sabouret
|